HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors SA Migueles, AC Laborico, WL Shupert, MS Sabbaghian, R Rabin, ... Nature immunology 3 (11), 1061-1068, 2002 | 1266 | 2002 |
VDJdb: a curated database of T-cell receptor sequences with known antigen specificity M Shugay, DV Bagaev, IV Zvyagin, RM Vroomans, JC Crawford, G Dolton, ... Nucleic acids research 46 (D1), D419-D427, 2018 | 506 | 2018 |
Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life M Reyman, MA van Houten, D van Baarle, AATM Bosch, WH Man, ... Nature communications 10 (1), 4997, 2019 | 436 | 2019 |
T cell responses to viral infections–opportunities for peptide vaccination S Rosendahl Huber, J van Beek, J de Jonge, W Luytjes, D van Baarle Frontiers in immunology 5, 171, 2014 | 272 | 2014 |
High viral burden in the presence of major HIV‐specific CD8+ T cell expansions: evidence for impaired CTL effector function S Kostense, GS Ogg, EH Manting, G Gillespie, J Joling, K Vandenberghe, ... European journal of immunology 31 (3), 677-686, 2001 | 248 | 2001 |
Persistent numbers of tetramer+ CD8+ T cells, but loss of interferon-γ+ HIV-specific T cells during progression to AIDS S Kostense, K Vandenberghe, J Joling, D Van Baarle, N Nanlohy, ... Blood, The Journal of the American Society of Hematology 99 (7), 2505-2511, 2002 | 245 | 2002 |
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia W Scheper, S van Dorp, S Kersting, F Pietersma, C Lindemans, S Hol, ... Leukemia 27 (6), 1328-1338, 2013 | 229 | 2013 |
Dysfunctional Epstein-Barr virus (EBV)–specific CD8+T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non … D van Baarle, E Hovenkamp, MFC Callan, KC Wolthers, S Kostense, ... Blood, The Journal of the American Society of Hematology 98 (1), 146-155, 2001 | 209 | 2001 |
Impaired recovery of Epstein-Barr virus (EBV)—specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at … P Meij, JWJ van Esser, HGM Niesters, D van Baarle, F Miedema, N Blake, ... Blood 101 (11), 4290-4297, 2003 | 170 | 2003 |
Recognition of homo-and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes A Boon, G De Mutsert, D Van Baarle, DJ Smith, AS Lapedes, ... The Journal of Immunology 172 (4), 2453-2460, 2004 | 168 | 2004 |
The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a … JSF Sanders, FJ Bemelman, AL Messchendorp, CC Baan, D van Baarle, ... Transplantation 106 (4), 821-834, 2022 | 167 | 2022 |
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, ... The Lancet Oncology 22 (12), 1681-1691, 2021 | 167 | 2021 |
Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue D van Baarle, S Kostense, MHJ van Oers, D Hamann, F Miedema Trends in immunology 23 (12), 586-591, 2002 | 163 | 2002 |
Frequencies and role of regulatory T cells in patients with (pre) malignant cervical neoplasia J Visser, HW Nijman, BN Hoogenboom, P Jager, D Van Baarle, ... Clinical & Experimental Immunology 150 (2), 199-209, 2007 | 153 | 2007 |
Immunogenicity and reactogenicity of vaccine boosters after Ad26. COV2. S priming RSG Sablerolles, WJR Rietdijk, A Goorhuis, DF Postma, LG Visser, ... New England Journal of Medicine 386 (10), 951-963, 2022 | 149 | 2022 |
Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review M Weltevrede, R Eilers, HE de Melker, D van Baarle Experimental gerontology 77, 87-95, 2016 | 147 | 2016 |
Changes in the Composition of Circulating CD8+ T Cell Subsets during Acute Epstein-Barr and Human Immunodeficiency Virus Infections in Humans MTL Roos, RAW van Lier, D Hamann, GJ Knol, I Verhoofstad, ... The Journal of infectious diseases 182 (2), 451-458, 2000 | 147 | 2000 |
Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome PJA de Pagter, R Schuurman, H Visscher, M de Vos, M Bierings, ... Biology of Blood and Marrow Transplantation 14 (7), 831-839, 2008 | 140 | 2008 |
Distribution of immune cells in the human cervix and implications for HIV transmission RT Trifonova, J Lieberman, D van Baarle American journal of reproductive immunology 71 (3), 252-264, 2014 | 129 | 2014 |
Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort CHBS van den Berg, BPX Grady, J Schinkel, T van de Laar, ... PloS one 6 (11), e27555, 2011 | 124 | 2011 |